PhD Defense: Advancing Therapeutic Drug Monitoring of oral targeted anticancer drugs; analytical and clinical studies ...

This could help make treatments safer and more precise, leading to better outcomes for cancer patients. Scientists in Japan have developed a new way to do just that using tiny gol ...

Background Voriconazole is approved for treatment of invasive aspergillosis and other invasive fungal infections, but the role for therapeutic drug monitoring (TDM) is not clear. Methods We ...

Gold nanoparticles are promising drug carriers for cancer therapy and targeted drug delivery, but tracking the movement of ...

In this study, pharmacogenomics and therapeutic drug monitoring were used to evaluate the clinical effectiveness of genotyping chronic pain patients on analgesic therapy. It was hypothesized that ...

The global therapeutic drug monitoring market is poised for significant expansion, with projections indicating a rise from USD 1,203.9 million in 2024 to an impressive USD 2,527.9 million by 2034.

Treatment decisions need to be based ... are changing rapidly at this time. Optimizing therapeutic strategies for cancer patients who are over 65 years of age remains a challenge.

Breakthrough study uses chromosome physical properties to monitor breast cancer therapy outcomes and predict recurrence ...

Gold nanoparticles (AuNPs) have emerged as promising drug carriers for cancer therapy and targeted drug delivery but tracking ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment strategies.